‘Breakthrough’ eye-pressure sensor trial begins in Germany
(Image courtesy of Implandata)
Implandata Ophthalmic Products announced that the first patient in its international, multi-center, ARGOS-SC01 clinical study has been successfully implanted with its novel pressure sensor. This first-in-human clinical study is being conducted to validate the suprachoroidally placed Eyemate-SC, a sensor implant for continual monitoring of intraocular pressure (IOP).
While Implandata’s already CE-marked Eyemate-IO intraocular sensor implant is intended for use in glaucoma patients undergoing cataract surgery, the Eyemate-SC device allows implantation in glaucoma patients not indicated for ca...
Source: Mass Device - December 3, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Optical/Ophthalmic Research & Development Implandata Ophthalmic Products Source Type: news
Google ’s Verily spikes glucose-sensing lens project with Novartis’ Alcon
Google (NSDQ:GOOG) life sciences company Verily said late last week that it is putting its joint project with Novartis (NYSE:NVS) unit Alcon to develop a glucose-sensing contact lens on hold due to difficulties in obtaining reliable tear glucose readings.
The project, which began in 2014, aimed to develop a contact lens that could measure glucose levels for individuals living with diabetes, according to a blog post from Verily chief technical officer Brian Otis.
But measuring glucose levels from tear glucose has proven to be unreliable, according to the blog posting.
“Our clinical work on the glucose-sensing lens...
Source: Mass Device - November 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diabetes Optical/Ophthalmic Research & Development Alcon google Novartis Verily Source Type: news
Alphabet's Verily shelves glucose-sensing contact lens project with Novartis
Two more smart contact lenses, for presbyopia and cataract surgery recovery, are still in the works. (Source: mobihealthnews)
Source: mobihealthnews - November 16, 2018 Category: Information Technology Source Type: news
Blocking 'secondary cataracts'
(University of Delaware) Cataracts surgery is a modern-day medical marvel, but even 10 years after a procedure, so-called secondary cataracts can form. UD researchers are identifying what's behind that and how to stop it. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2018 Category: International Medicine & Public Health Source Type: news
Sierra Leone: Chinese Medical Team Performs Free Cataract Surgery in Kenema
[Concord] Charles Jusu, who is over 60, has finally regained his complete eyesight. He is one of the beneficiaries of free cataract surgery being conducted by a team of Chinese medical experts from Hunan Province. His two eyes were almost rendered useless after being affected by cataract for the past years. But with the intervention of the medical team, his eyesight has been revived. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 9, 2018 Category: African Health Source Type: news
OCT Screening Before Cataract Surgery Can Improve Outcomes OCT Screening Before Cataract Surgery Can Improve Outcomes
Routine screening with optical coherence tomography (OCT) before cataract surgery can identify overlooked pathologies, researchers say, but cost might be an issue.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 2, 2018 Category: Consumer Health News Tags: Ophthalmology News Source Type: news
Cataract Surgery, Hearing Aids May Curb Cognitive Decline Cataract Surgery, Hearing Aids May Curb Cognitive Decline
Sensory deprivation is a risk factor for cognitive decline and dementia, but will correcting impaired hearing and vision prevent these outcomes? Yes, these studies suggest.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 30, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Philips board backs reappointment of CEO van Houten, CFO Bhattacharya | Personnel Moves – October 29, 2018
Royal Philips (NYSE:PHG) said today that its board of directors is backing the re-appointment of Frans van Houten as its president and CEO and Abhijit Bhattacharya as chief financial officer and board member.
CEO van Houten has been at the head of Philips since 2011, while Bhattacharya joined the company in 2015, Amsterdam-based Philips said.
During his time in the corner office, van Houten led the initial public offering for Philips Lighting in May 2016 and has increased R&D investments and led acquisitions including Volcano, Spectranetics, Wellcentive and VitalHealth.
Board members will officially vote on a new CEO ...
Source: Mass Device - October 29, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured aligntechnology Bovie Medical Corp. Clearside Biomedical cromsource Fisher & Paykel Healthcare Harvard Bioscience Inc. Ra Medical RenovaCare royalphilips Sight Sciences Source Type: news
Diabetes No Barrier to Cataract Surgery
(MedPage Today) -- Procedure shouldn ' t be delayed solely on basis of HbA1c levels, researcher says (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - October 28, 2018 Category: Endocrinology Source Type: news
Surgeon Age Doesn't Affect Cataract Surgery Outcomes Surgeon Age Doesn't Affect Cataract Surgery Outcomes
Late-career surgeons perform a large proportion of cataract operations, and they do it with an overall low rate of adverse events, a Canadian study suggests.Reuters Health Information (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - October 26, 2018 Category: Opthalmology Tags: Ophthalmology News Source Type: news
Surgeon age doesn't affect cataract surgery outcomes
(Reuters Health) - Late-career surgeons perform a large proportion of cataract operations, and they do it with an overall low rate of adverse events, a Canadian study suggests. (Source: Reuters: Health)
Source: Reuters: Health - October 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Nigeria:Samsung Heavy Industries Supports Eye Surgery for 102 Nigerian
[Guardian] With the assistance of Samsung Heavy Industries of Nigeria (SHIN), 102 Nigerian patients with cataracts and at risk of blindness have successfully recovered their eyesight with Vision Care, an organisation under the World Health Organisation (WHO). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 24, 2018 Category: African Health Source Type: news
Carl Zeiss Meditec buys cataract surgery device maker IanTech
Carl Zeiss Meditec (ETR:AFX) said today it inked a deal to acquire micro-interventional cataract surgery tech dev IanTech for an undisclosed amount.
Reno, Nev.-based IanTech designed and developed the miLOOP device intended for micro-interventional cataract surgery.
The system uses thin, super-elastic, self-expanding nitinol filament technology and is intended to allow the user to achieve full thickness lens fragmentation for any grade cataract to reduce intraocular ultrasonic vibrations and phase power, according to the company’s website.
“We expect that IanTech will complement our leading portfolio of equipment ...
Source: Mass Device - October 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Mergers & Acquisitions Optical/Ophthalmic Carl Zeiss Meditec iantech Source Type: news
Alcon to Develop SMART Suite Digital Health Platform for Cataract Surgery
Alcon, the global leader in eye care and a division of Novartis, today announced plans to develop the SMART Suite by Alcon, an innovative, digital platform that is designed to streamline, simplify and improve cataract surgery for surgeons and patients. (Source: eHealth News EU)
Source: eHealth News EU - October 23, 2018 Category: Information Technology Tags: Featured Industry Business and Industry Source Type: news
Alcon to develop SMART Suite digital health platform for cataract surgery
Alcon, the global leader in eye care and a division of Novartis, today announced plans to develop the SMART Suite by Alcon, an innovative, digital platform that is designed to streamline, simplify and improve cataract surgery for surgeons and patients. (Source: World Pharma News)
Source: World Pharma News - October 23, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news
